AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.3 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Clinical Research | Publishing Language: Chinese

Clinical efficacy of wrist-ankle acupuncture for postherpetic neuralgia and its effects on serum levels of NaV1.7 and CGRP

Weiqun LIU1,2, Jinxiu ZHANG3, Xiao CHEN1, Jianrong CAI1, Xinqiang LIN1, Zhen WEI2( )
Department of Pain Medicine, Affiliated Hospital of Putian University, Putian 351100, Fujian Province, China
Department of Pain Medicine, Second People's Hospital Affiliated of Fujian University of TCM, Fuzhou 350003
Department of Anesthesiology, Second Hospital of Zhangzhou
Show Author Information

Abstract

Objective

To observe the clinical efficacy of wrist-ankle acupuncture for postherpetic neuralgia (PHN) and its effects on serum levels of voltage-gated sodium channel 1.7 (NaV1.7) and calcitonin gene-related peptide (CGRP).

Methods

A total of 90 PHN patients were randomized into a wrist-ankle acupuncture group (45 cases, 2 cases dropped out) and a western medication group (45 cases, 1 case dropped out, 1 case was discontinued). In the western medication group, the topical 5% lidocaine gel plaster was used locally. In the wrist-ankle acupuncture group, wrist-ankle acupuncture was applied 30 min each time, once a day, 5-day treatment was as one course, with 2-day interval between courses. The treatments lasted for 4 weeks in both groups. The scores of visual analogue scale (VAS), Pittsburgh sleep quality index (PSQI), self-rating anxiety scale (SAS), and self-rating depression scale (SDS) were observed before treatment, after 2 and 4 weeks of treatment, and in the follow-up of 4 weeks after treatment completion. The serum levels of NaV1.7 and CGRP were measured before and after 4 weeks of treatment. The use of rescue analgesics and the occurrence of adverse reactions were recorded, and the clinical efficacy was evaluated after 4 weeks of treatment.

Results

Compared with those before treatment, the scores of VAS, PSQI, SAS and SDS were decreased after 2 and 4 weeks of treatment, and in follow-up (P<0.05). After 4 weeks of treatment and in follow-up, the above scores in the wrist-ankle acupuncture group were lower than those in the western medication group (P<0.05). After 4 weeks of treatment, the serum levels of NaV1.7 and CGRP were decreased compared with those before treatment (P<0.05), and the serum levels of NaV1.7 and CGRP in the wrist-ankle acupuncture group were lower than those in the western medication group (P<0.05). During the trial, 5 cases in the wrist-ankle acupuncture group and 11 cases in the western medication group required rescue analgesics, with no statistical difference between the two groups (P>0.05). The incidence of adverse reactions was 9.3% in the wrist-ankle acupuncture group, which was lower than 27.9% in the western medication group (P<0.05). The total effective rate in the wrist-ankle acupuncture group was 90.7%(39/43), that of the western medication group was 83.7%(36/43), there was no statistical difference between the two groups (P>0.05).

Conclusion

Wrist-ankle acupuncture can effectively treat PHN, reduce pain, improve sleep quality and relieve negative emotions. Its mechanism may relate to the down-regulation of serum NaV1.7 and CGRP levels.

References

【1】
【1】
 
 
Chinese Acupuncture&Moxibustion
Pages 199-205

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
LIU W, ZHANG J, CHEN X, et al. Clinical efficacy of wrist-ankle acupuncture for postherpetic neuralgia and its effects on serum levels of NaV1.7 and CGRP. Chinese Acupuncture&Moxibustion, 2026, 46(2): 199-205. https://doi.org/10.13703/j.0255-2930.20250917-k0001

493

Views

7

Downloads

0

Crossref

0

Scopus

Received: 17 September 2025
Published: 25 November 2025
© The Editorial Office of CHINESE ACUPUNCTURE & MOXIBUSTION